01. History

History of the Cancer Center of Kansas

Headquartered in the Great Plains of Wichita, Kansas, the Cancer Center of Kansas is a health care facility that specializes in the treatment of all types of cancer and blood disorders, including mesothelioma. Since its founding in 1975, the center has expanded to 20 sites throughout the state of Kansas.

The Cancer Center of Kansas was founded by Dr. Harry Hynes. Hynes was joined by a partner, Dr. Shaker Dakhil, in 1980, and from there the treatment center continued to grow. By 2018, more than 15 physicians and health care providers, representing a range of specialties, worked at the Cancer Center of Kansas. These doctors not only treat and see patients at the center’s main location in Wichita, but also travel to other satellite locations each week to bring quality care to patients throughout the state of Kansas. Dr. Hynes, the hospital’s founder, passed away in 2000, the company is now led by Dr. Shaker Dakhil.

02. Specializations

The Cancer Center of Kansas Specializations

  • Biological therapy
  • Blood and marrow transplants
  • Chemotherapy
  • Clinical trials
  • Diagnostic imaging
  • Hormonal therapy
  • Radiation therapy
  • Surgery
  • Targeted therapy
03. Accreditations

The Cancer Center of Kansas Accreditations

  • Wichita Business Journal Innovation Award Honoree
  • Wichita Kansas Reader’s Choice Favorite for Best Hospital for Cancer Care
04. Mesothelioma Clinical Trials

Mesothelioma Clinical Trials at Cancer Center of Kansas

The following clinical trials are in progress or actively recruiting participants at Cancer Center of Kansas:

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Conditions: Carcinoma, Neoplasms, Carcinoma, Squamous Cell, Adenocarcinoma, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Nasopharyngeal Carcinoma, Cholangiocarcinoma, Carcinoma, Basal Cell, Gastrointestinal Stromal Tumors, Carcinoid Tumor, Carcinoma, Transitional Cell, Carcinoma, Adenoid Cystic, Adenocarcinoma of Lung, Teratoma, Carcinoma, Neuroendocrine, Pheochromocytoma, Seminoma, Cystadenocarcinoma, Serous, Choriocarcinoma, Carcinoma, Endometrioid, Cystadenocarcinoma, Paraganglioma, Chordoma, Hemangiosarcoma, Fibromatosis, Aggressive, Adenocarcinoma, Mucinous, Nerve Sheath Neoplasms, Trophoblastic Neoplasms, Gestational Trophoblastic Disease, Neurofibrosarcoma, Thyroid Neoplasms, Fibroma, Cystadenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Vulvar Neoplasms, Sex Cord-Gonadal Stromal Tumors, Adrenocortical Carcinoma, Carcinoma, Islet Cell, Paget Disease, Extramammary, Adenocarcinoma, Papillary, Carcinoma, Acinar Cell, Adenocarcinoma, Bronchiolo-Alveolar, Neoplasms, Unknown Primary, Mixed Tumor, Mullerian, Carcinoma, Giant Cell, Adenocarcinoma, Clear Cell

Last Updated: August 1, 2023

Status: Recruiting

Locations: Birmingham, AL. Mobile, AL. Anchorage, AK. Miami Beach, FL.